Robert LeBoyer

Senior Equity Research Analyst, Noble Capital Markets, Biotechnology

Robert LeBoyer is the Senior Equity Research Analyst at Noble Capital Markets for Biotechnology – Mr. LeBoyer began his research career at Prudential Securities, and has previously been a Senior Biotechnology Analyst at Brown Brothers Harriman and Leerink Swann, joining Noble from Ladenburg Thalmann. Robert holds a BA in Economics from Tulane University and an MBA from Columbia Business School. Mr. LeBoyer is a FINRA-licensed analyst.